KIF23 promotes triple negative breast cancer through activating epithelial-mesenchymal transition | Zendy

Wei Jian | Zendy; Xiaochong Deng | Zendy; Amik Munankarmy | Zendy; Oyungerel Borkhuu | Zendy; Changle Ji | Zendy; Xuehui Wang | Zendy; Wenfang Zheng | Zendy; Yunhe Yu | Zendy; Xiqian Zhou | Zendy; Lin Fang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

KIF23 promotes triple negative breast cancer through activating epithelial-mesenchymal transition

Author(s) -

Wei Jian,

Xiaochong Deng,

Amik Munankarmy,

Oyungerel Borkhuu,

Changle Ji,

Xuehui Wang,

Wenfang Zheng,

Yunhe Yu,

Xiqian Zhou,

Lin Fang

Publication year - 2021

Publication title -

gland surgery

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 0.643

H-Index - 22

eISSN - 2227-8575

pISSN - 2227-684X

DOI - 10.21037/gs-21-19

Subject(s) - gene knockdown , triple negative breast cancer , breast cancer , oncogene , cancer research , microrna , epithelial–mesenchymal transition , cancer , western blot , biology , oncology , medicine , cell cycle , cell culture , metastasis , genetics , gene

KIF23 is a member of kinesin family, recent researches indicate KIF23 plays an important role in the proliferation and migration of malignant cancer cells. While the function and specific molecule mechanism of KIF23 in triple negative breast cancer remains unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research